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Summary
A new neonatal syndrome characterized by intrauterine
growth retardation, lactic acidosis, aminoaciduria, liver
hemosiderosis, and early death was recently described.
The pathogenesis of this disease is unknown. The mode
of inheritance is autosomal recessive, and so far only 17
cases have been reported in 12 Finnish families. Here
we report the assignment of the locus for this new disease
to a restricted region on chromosome 2q33-37. We
mapped the disease locus in a family material insufficient
for traditional linkage analysis by using linkage dise-
quilibrium, a possibility available in genetic isolates such
as Finland. The primary screening of the genome was
performed with samples from nine affected individuals
in five families. In the next step, conventional linkage
analysis was performed in eight families, with a total of
12 affected infants, and finally the locus assignment was
proved by demonstrating linkage disequilibrium to the
regional markers in 20 disease chromosomes. Linkage
analysis restricted the disease locus to a 3-cM region
between markers D2S164 and D2S2359, and linkage
disequilibrium with the ancestral haplotype restricted
the disease locus further to the immediate vicinity of
marker D2S2250.
Introduction
A new neonatal metabolic disease has recently been de-
scribed (Fellman et al. 1998). This disease is character-
ized by severe intrauterine growth retardation, fulminant
lactic acidosis during the first day of life, Fanconi-type
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aminoaciduria, and abnormalities in iron metabolism,
including liver hemosiderosis. Affected infants fail to
thrive, and they die neonatally or in early infancy. The
disease is distinct from other lactic acidoses, neonatal
hemochromatosis, and hepatitis (Fellman et al. 1998).
The pathogenesis of this disorder is unknown.
Seventeen patients in 12 families have been diagnosed
in Finland since 1965. The parents of the patients are
healthy, and at least eight families have one or two
healthy children. The male/female ratio of the patients
has been 5/12. The occurrence of the disease in sibships
and in both sexes in families with healthy parents is
consistent with autosomal recessive inheritance. Since
this disease has not been described elsewhere in the
world, it represents a new member of the Finnish disease
heritage, a group of 30 rare monogenic diseases enriched
or encountered only in Finland (Norio et al. 1973; de
la Chapelle 1993). The genealogies of the affected fam-
ilies have been traced back to themid-19th century—and
the oldest genealogy to the late 17th century—by using
church records. Most of the ancestors were born in rural
communities in eastern and central Finland, remote from
the majority of the population (fig. 1), and some ancient
connections between the families have been established
(Fellman et al. 1998).
The incidence in Finland can be roughly estimated,
from the 14 cases diagnosed 1985–1997, to be 1/56,000
newborns, with a disease allele frequency of .004 and a
carrier frequency of 1/120. However, the disease is prob-
ably underdiagnosed and the true allele frequency may
be higher.
Here we report the assignment of the locus of this new
metabolic syndrome to a restricted region on chromo-
some 2q33-37. The initial genome screen was carried
out by genotyping just nine affected individuals. This
modification of the haplotype-sharing method (Houwen
et al. 1994) has been successfully used in the identifi-
cation of other disease loci of the Finnish disease heritage
(Ma¨kela¨-Bengs et al. 1998; Pekkarinen et al. 1998). Fur-
ther linkage analyses with markers on the promising
chromosomal region were performed in eight families.
This family material was too restricted to establish a
Visapa¨a¨ et al.: Metabolic Syndrome Locus on 2q 1397
Figure 1 Birthplaces of the patients’ great-grandparents on a
map of Finland.
Figure 2 Pedigrees used in the linkage and linkage-disequilib-
rium studies. Arrows indicate individuals whose DNA samples were
analyzed in the initial genome screen. Asterisks denote individuals
whose DNA was isolated from paraffin-embedded tissue samples.
confirmed linkage. However, since this syndrome be-
longs to the Finnish disease heritage, and since the pa-
tients most probably have one common ancestor, we
were able to confirm the locus assignment by demon-
strating linkage disequilibrium to the regional markers.
Subjects and Methods
Patients, Families, and DNA Samples
All of the 14 affected infants diagnosed 1985–1997
were included in this study (Fellman et al. 1998). The
infants were born near term but were severely growth-
retarded, with an average birth weight of 1,560 g, which
corresponds to a 4 SD score for the gestational age.
At birth they had a normal umbilical pH, but during
the first day of life they developed severe lactic acidosis;
by the age of 24 h, the mean arterial blood pH was 7.0
(normal, 7.35–7.45), base excess 23 mmol/l (normal,
2.5 mmol/l), and lactate 12 mmol/l (normal, 0.7–1.8
mmol/l). All the infants had Fanconi-type aminoaciduria
and hemosiderosis of the liver and spleen. In four infants
studied, the serum ferritin concentration was increased
tenfold, transferrin was low (0.54–0.76 g/l; normal,
1.75–3.13 g/l), and transferrin saturation increased
(61%–100%; normal, !52%). No deficiency in respi-
ratory-chain oxygen consumption or enzyme activity
was found. No neurological abnormality was detected
in these infants. Despite intensive care and alkali therapy,
seven infants died at the age of 1–3 days, and seven at
the age of 0.5–4 months (Fellman et al. 1998).
Cultured fibroblast specimens were available from 12
patients, and paraffin-embedded tissue samples could be
used from the 2 remaining patients. Blood samples from
parents and healthy siblings were collected after written
informed parental consent was obtained. The pedigrees
of the individuals included in this study are shown in
figure 2. In one family (family 1) the parents were second
cousins, and two families (mother in family 4 and father
in family 5) had ancestors with the same surname living
in neighboring houses at the end of the 18th century,
but the consanguinity could not be confirmed, since the
presumable common ancestor had lived before the es-
tablishment of local church records (Fellman et al.
1998). Families 1–8, with 12 affected and 26 healthy
family members, were included in the linkage studies.
For the linkage disequilibrium studies, the family ma-
terial was completed with the affected infants of families
9 and 10.
As controls for the linkage disequilibrium analyses,
46 parental DNA samples collected for the mapping of
infantile-onset spinocerebellar ataxia (IOSCA) and hy-
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drolethalus syndrome were used. These diseases also be-
long to the Finnish disease heritage, and the birthplace
patterns of ancestors are highly similar to that observed
in this new disease (Salonen 1986; Varilo et al. 1996).
Consequently, these control samples ought to represent
the same subpopulation of Finland in which this disease
is enriched.
Total DNA was extracted from cultured fibroblasts
and peripheral leukocytes according to standard pro-
cedures. The paraffin-embedded tissue samples were de-
paraffinized and the DNA released from cells by the
rapid lysis method (Isola et al. 1994).
Marker Genotyping
A slightly modified Weber screening set (Sheffield et
al. 1995) of 380 polymorphic microsatellite markerswas
used in the genome screen. The primers were purchased
from the Nordic HumanGenome Initiative. Themarkers
were amplified by PCR, with a pipetting robot used for
the PCR reactions (Biomek 2000, Beckman). One of the
primers was fluorescence 5′–end labeled (cyp5), and the
PCR products were separated on an automated laser-
fluorescence DNA sequencer (ALF Express, Pharmacia).
Genotype data were processed with the ALLELELINKS
computer program (Pharmacia).
In the denser mapping of the critical chromosomal
region, marker maps from Ge´ne´thon (Dib et al. 1996),
the Genetic Location Database of the University of
Southampton, and the Whitehead Institute were used.
The primer sequences of markers D2S104, D2S433, and
D2S1354 originated from the Genome Database. The
primer sequences of the other markers originated from
the Ge´ne´thon collection (Dib et al. 1996). The primers
were 5′–end labeled with 32P, and the PCR reactions and
the size analysis of the PCR products were performed
as described elsewhere (Aaltonen et al. 1993).
Radiation Hybrid Panels
In the radiation hybrid mapping (Goss and Harris
1975; Cox et al. 1990), Stanford medium- and high-
resolution RH panels were used (G3 and TNG, respec-
tively). The raw hybrid data of the G3 panel, with mark-
ers D2S434, D2S173, D2S433, and D2S163, and of the
TNG panel, with marker D2S173, available on the Stan-
ford Human Genome Center web pages, were used. The
other ordered markers were typed in both panels twice,
or three times if the two typings were ambiguous. The
markers were amplified by PCR and the products were
separated by electrophoresis on 1.5% agarose gels
stained with ethidium bromide.
Statistical Analyses
Two-point linkage analyses were performed with the
MLINK option of the LINKAGE package computer pro-
grams, version FASTLINK 2.2 (Lathrop and Lalouel
1984), assuming autosomal recessive inheritance, com-
plete penetrance, no phenocopies, and a disease allele
frequency of .01. The consanguinity of the parents of
family 1 was taken into account in the linkage analysis.
Two-point linkage disequilibrium analyses were per-
formed with the DISLAMB computer program, andmul-
tipoint linkage disequilibrium analysis was performed
with the DISMULT computer program (Terwilliger
1995). A disease allele frequency of .01 was assumed in
the analyses. In the DISMULT program, the distances
between the analyzed markers are fixed, and the likeli-
hood is maximized over a (the proportion of disease
alleles originally associated with a certain allele) and n
(the number of generations since the introduction of the
founder disease allele into the population).
The RH mapping data were analyzed with the FOR-
TRAN program RHMAXLIK of the RHMAP package
version 3.0 (Boehnke et al. 1991; Lange et al. 1995;
Lunetta et al. 1996). This program orders the markers
and calculates marker distances in centirays (cR). It al-
lows the use of data from several RH panels simulta-
neously, which was very important in this study because
the ordered markers were too close to each other to be
ordered with the Stanford G3 RH panel only, and too
distant from each other to be ordered with the Stanford
TNG RH panel alone. We used the data of both these
panels and the branch and bound ordering option,which
ensures that the best locus order is identified. By com-
paring the raw RH data (G3 panel) of the markers, or-
dered in relation to each other, to the raw RH data of
the flanking markers (available on the Stanford Human
Genome Center web pages), we concluded which mark-
ers must be located at the ends of the ordered region.
Then we chose from the probable locus orders given by
computer analysis the most probable ordermatching this
conclusion. The marker distances were converted from
centirays to centimorgans by dividing the known total
length (in centimorgans) of the linked region propor-
tional to the marker distances in centirays.
Results
Genome Screen and Linkage Analysis
DNA samples from just nine individuals were used in
the initial genome scan: four affected sibpairs and the
affected infant of family 5 (indicated by arrows in fig.
2). The affected infant of family 5 was included because
the mother of family 4 and the father of family 5 were
believed to be distant relatives, and consequently they
could share a long chromosomal segment around the
disease locus. The parents of family 1 were second cous-
ins, and we assumed that the affected sibs in this family
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Figure 3 Pairwise LOD scores between the disease and 15
marker loci on 2q33-37 in eight families.
were homozygotes with markers flanking the potential
disease locus.
The analysis of the genotypes in the initial genome
scan was performed in a very simple and rapid way by
simply comparing the genotypes of sibs in each family
and looking for markers on which each sibpair carried
identical genotypes. After analyzing just 25 markers of
the genome scan panel, we found two adjacent markers
on chromosome 2q—D1S1649 (which maps to chro-
mosome 2 despite its name) and D2S434, 5-cM
apart–revealing identical genotypes in each of four sib-
pairs. In addition, marker D2S1363, 14 cM away from
marker D2S434, revealed identical genotypes in three
sibpairs. In family 1, whose parents were second cousins,
the sibs were homozygous for all these three markers.
These markers were then genotyped in the complete fam-
ily material. No obligatory recombinations could be
identified betweenmarker D2S434 and the disease (max-
imum LOD score 3.0 at recombination fraction [v] 0),
whereas markers D1S1649 and D2S1363 showed oblig-
atory recombinations between the markers and the
disease.
The next step was to analyze several markers around
marker D2S434 on chromosome 2q33-37 in the com-
plete family material.Multiplemarkers betweenD2S164
and D2S2359 provided positive LOD scores (maximum
LOD scores 0.91–3.88 at ), suggesting linkage onv  0
a 3-cM region. In the constructed haplotypes in the fam-
ilies, no obligatory recombination events could be de-
tected between the disease and a total of 11 markers on
this 3-cM region. The results of two-point linkage anal-
ysis with 15 markers on 2q33-37 are summarized in
figure 3.
Linkage Disequilibrium and Radiation Hybrid Mapping
of the Critical Region
To confirm the linkage and to restrict the critical chro-
mosomal region, we performed linkage disequilibrium
analysis with all the markers providing maximum two-
point LOD scores at . Since we had only 20 affectedv  0
and 16 nonaffected chromosomes in our familymaterial,
we obtained additional nonaffected chromosomes from
regionally selected control samples. In total, we used 20
disease and 108 nondisease chromosomes in the linkage
disequilibrium studies.
The results of the linkage disequilibrium analysis for
each of the 11 markers on the linkage region on 2q33-
37 are presented in table 1. Marker D2S2250 showed
the most significant linkage disequilibrium; all the dis-
ease chromosomes carried the same allele 4, the pro-
portion of which in the nondisease chromosomes was
21%, with a P value of 1012. This confirmed the as-
signment of the disease locus to the vicinity of this
marker. Markers D2S433 and D2S2244 also provided
significant P values in the linkage disequilibrium anal-
ysis, and several flanking markers showed suggestive,
but not significant, evidence of linkage disequilibrium.
To be able to carry out multipoint linkage disequilib-
rium analysis and to correctly build the ancestral hap-
lotypes, we performed radiation hybrid mapping of the
critical markers to confirm their order. The 11 linked
markers were too close to each other to be ordered with
the medium-resolution RH panel, but the gap between
markers D2S2179 and D2S2250 turned out to be so
long that all the markers were not linked in the high-
resolution RH panel. We typed the markers in both pan-
els and performed the RH data analysis with a computer
program that allows the use of data from both panels
simultaneously. Based on this analysis, the most prob-
able marker order and the approximatemarker distances
(converted to centimorgans) over the linked re-
gion are as follows: cen–D2S2210–0.4 cM–D2S434–
0.3 cM–D2S2249–0.2 cM–D2S173–0.1 cM–D2S104–
0.1 cM–D2S2179–0.4 cM–D2S2250–0.1 cM–D2S433–
0.3 cM–D2S1354–0.4 cM–D2S2244–0.4 cM–D2S163–
tel. The total map length from D2S2210 to D2S163 was
60 cR10,000.
The multipoint linkage disequilibrium analysis carried
out with these markers resulted in a maximum LOD
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Figure 4 Multipoint linkage disequilibrium analysis of 11mark-
ers in the 3-cM linkage region with 20 disease and 108 nondisease
chromosomes.
Table 1
Allele Frequencies of Disease and Nondisease Chromosomes and Two-Point Linkage Disequilibrium Analyses of
11 Marker Loci on 2q33-37
LOCUS
PERCENTAGE OF DISEASE CHROMOSOMES ( ) / PERCENTAGE OFn  20
CONTROL CHROMOSOMES ( )n  108
x2
LRTa
P
VALUE lb1 2 3 4 5 6 7 8 9
D2S2210 15/23 35/18 50/57 0/1 0/1 ) ) ) ) .1 .4 .13
D2S434 0/20 40/17 10/33 45/20 5/6 0/4 ) ) ) 2.7 .05 .27
D2S2249 0/9 55/16 0/29 35/20 10/17 0/3 0/1 0/5 ) 8.7 .002 .45
D2S173 5/29 30/7 60/53 0/7 5/2 0/2 ) ) ) 2.4 .06 .23
D2S104 95/66 5/8 0/12 0/8 0/1 0/3 0/1 0/1 ) 8.0 .002 .85
D2S2179 0/7 95/66 5/14 0/1 0/4 0/5 0/1 0/2 ) 8.1 .002 .85
D2S2250 0/5 0/21 0/29 100/21 0/15 0/3 0/2 0/1 0/3 49.1 !.0001 1.00
D2S433 0/3 95/25 5/56 0/10 0/3 0/3 ) ) ) 34.5 !.0001 .93
D2S1354 0/9 0/4 100/71 0/14 0/1 0/1 ) ) ) 11.6 .0003 1.00
D2S2244 65/9 35/75 0/10 0/2 0/3 0/1 ) ) ) 24.0 !.0001 .61
D2S163 5/8 5/13 10/34 15/11 10/9 55/20 0/3 0/2 ) 6.6 .005 .43
a x2 statistic of the likelihood-ratio test (Terwilliger 1995).
b Proportion of excess of a certain allele in the disease-carrying chromosomes.
score of 30.9 in the immediate vicinity of marker
D2S2250 (fig. 4).
Haplotype Analysis
The haplotypes of disease chromosomes are shown in
table 2.The haplotypes of families 1–8 are presented as
paternal and maternal disease chromosomes. In families
9 and 10 the parental data were missing, and conse-
quently only the genotypes of the affected infants are
shown. For these cases, we constructed the disease hap-
lotypes based on the infants’ expected descent from the
same ancestors as the other affected individuals.
The 1-cM core haplotype cen-1-2-4-2-3-tel (D2S104-
D2S2179-D2S2250-D2S433-D2S1354) was observed in
18/20 of the disease chromosomes. One of the haplo-
types that differed from the core haplotype had different
alleles with markers D2S104 and D2S2179, and the
other had a different allele with marker D2S433. The
disease locus is probably very close to marker D2S2250,
since all the disease chromosomes carried the same allele
4, which was present in 21% of the nondisease chro-
mosomes. In addition, with marker D2S1354 all the dis-
ease chromosomes carried the same allele 3, but this
allele was also very common (71%) in the nondisease
chromosomes. On the centromeric side of marker
D2S2250, the critical DNA region was clearly restricted
by marker D2S2179, since the disease haplotype of the
mother of family 4 was entirely different from the core
haplotype with marker D2S2179 and the markers cen-
tromeric from it. On the telomeric side of marker
D2S2250, the critical chromosomal region remained less
definitive. With marker D2S433, the infant of family 10
carried allele 3 instead of the core haplotype allele 2.
However, allele 3 differs from allele 2 by one tetranu-
cleotide repeat only, and so a marker mutation in this
disease chromosome cannot be excluded, especially since
with marker D2S2244 this infant again carried allele 1,
which shows strong linkage disequilibrium with the dis-
ease. Therefore, the most critical DNA region is not def-
initely restricted by marker D2S433, but lies between
markers D2S2179 and D2S2244. Most probably, the
disease locus is in the immediate vicinity of marker
D2S2250.
Visapa¨a¨ et al.: Metabolic Syndrome Locus on 2q 1401
Table 2
Haplotypes of the Disease Chromosomes in the 3-cM Linkage Region
Family D2S2210 D2S434 D2S2249 D2S173 D2S104 D2S2179 D2S2250 D2S433 D2S1354 D2S2244 D2S163
1 P 2 4 4 2 1 2 4 2 3 1 6
1 M 2 4 4 2 1 2 4 2 3 1 6
2 P 3 2 2 3 1 2 4 2 3 2 6
2 M 1 3 2 5 1 2 4 2 3 1 4
3 P 3 2 2 3 1 2 4 2 3 1 6
3 M 3 4 2 3 1 2 4 2 3 2 6
4 P 3 2 2 3 1 2 4 2 3 1 6
4 M 1 4 5 1 2 3 4 2 3 2 5
5 P 3 2 2 3 1 2 4 2 3 1 1
5 M 3 4 4 3 1 2 4 2 3 1 4
6 P 2 4 4 2 1 2 4 2 3 1 3
6 M 2 2 2 3 1 2 4 2 3 2 6
7 P 2 4 4 2 1 2 4 2 3 1 5
7 M 3 2 2 3 1 2 4 2 3 1 6
8 P 3 2 2 3 1 2 4 2 3 2 6
8 M 3 3 2 3 1 2 4 2 3 2 6
9 O 1 5 2 3 1 2 4 2 3 2 2
9 O 2 4 4 2 1 2 4 2 3 1 3
10 O 3 2 5 3 1 2 4 2 3 1 6
10 O 2 4 4 2 1 2 4 3 3 1 4
NOTE.—P denotes paternal disease chromosome; M, maternal disease chromosome; and O, haplotype formed from genotypes of the affected
offspring (parental data missing). Underlining indicates alleles, which are part of the core haplotype shared with all disease chromosomes.
Discussion
In this study the disease locus was found by using
samples from just nine affected individuals in the initial
search. This efficient method of monitoring for shared
DNA regions has been used successfully in the identi-
fication of other monogenic disease loci of the Finnish
disease heritage (Ma¨kela¨-Bengs et al. 1998; Pekkarinen
et al. 1998). As in these earlier studies, we did not find
a conserved haplotype shared by all affected individuals
with the marker density used in the first stage of the
genome scan, but it proved successful to monitor for
shared haplotypes between siblings only and not in all
the affected individuals, although a common ancestor
was suspected in the distant past.
For the linkage analysis, we had DNA samples from
eight families, only four of which had two affected chil-
dren, and completely reliable disease locus assignment
could not be determined by conventional linkage anal-
ysis. However, the strong linkage disequilibrium, iden-
tified with the regional markers and providing a LOD
score of 30.9 in the multipoint analysis, confirmed the
locus assignment to the suggestively linked chromosomal
region. Linkage disequilibrium analysis has been used in
several mapping projects in the Finnish disease heritage
in the process of restricting the critical chromosomal
region before initiating the physical mapping or candi-
date gene analyses (Ha¨stbacka et al. 1992; Hellsten et
al. 1993; Sulisalo et al. 1994; Ho¨glund et al. 1995). Here
too, the linkage disequilibrium analysis restricted the
critical chromosomal region from the initial 3 cM to 1
cM, but we used it not only for the fine mapping of the
disease locus but also to prove the presumptive linkage
in this very small family material. To initiate a gene-
mapping attempt with such family material, one would
have to assume (a) that the families have one common
ancestor and consequently there is strong linkage dise-
quilibrium between the markers close to the disease lo-
cus, and (b) that the mutation is young enough for link-
age disequilibrium to be detected with a reasonable
marker density. In many diseases in the Finnish disease
heritage, 190% of the disease chromosomes carry the
same ancestral mutation and linkage disequilibrium can
be detected on chromosomal regions 2–13 cM, and we
rightly expected this to be the case with this disease also
(Peltonen et al. 1995).
Since 18/20 of the disease chromosomes shared the
same 1-cM core haplotype with five markers, and the 2
other disease chromosomes also partly shared this an-
cestral haplotype, all the families probably have one
common ancestor and carry the same disease mutation.
Significant linkage disequilibrium spans an interval of 1
cM in two-point analyses, a distance comparable to the
significant two-point linkage disequilibrium observed in
disease chromosomes in another Finnish disease, IOSCA
(Nikali et al. 1995). The birthplace patterns of ancestors
also resemble each other in these two diseases. The mu-
tations were most probably introduced into the Finnish
population around the same time period, some 30–40
generations ago (Varilo et al. 1996). In the 16th century,
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the great east-to-west migration of the population and
the inhabitation of wilderness spread rare genes to rural
subpopulations, which remained surprisingly stable until
World War II and present-day industrialization (Norio
1973; Solantie 1988). The clustering of the birthplaces
of the ancestors of this disease mirrors this internal mi-
gration in Finland.
As expected, the disease haplotypes of the parents of
family 1 are identical over a long chromosomal region,
because the parents are second cousins. On the other
hand, and contrary to our assumption, the disease hap-
lotypes of the mother of family 4 and the father of family
5 did not show similarity on a region longer than that
of the other disease chromosomes, even though we as-
sumed that they had a common ancestor ∼10 genera-
tions ago. Our assumption of distant consanguinity may
have been incorrect, the disease mutation may have de-
scended to these families from other ancestors, or ab-
normally numerous recombinations may have taken
place in this chromosomal region over a relatively short
time.
We are in the process of constructing a physical map
of the critical chromosomal region so we can restrict the
gene locus more accurately and then localize and analyze
the possible candidate genes and expressed sequence tags
(ESTs) in this region. The total RH map length of the
3-cM linkage region was 60 cR10,000. Since, on average,
1 cR10,000 is 25 kb (Lunetta et al. 1996), the physical
length of the most critical 1-cM region may be ∼500 kb,
which is feasible for transcript mapping. In the Human
Gene Map of the National Center for Biotechnology
Information, there are four cloned genes and 20 ESTs
mapped between markers D2S164 and D2S163, an in-
terval corresponding to our linkage region. The four
genes are KIAA0173 and KIAA0236 genes, the function
of which has not yet been well defined (Nagase et al.
1996a, 1996b); the villin gene (VIL1), which is expressed
mainly in cells that develop a brush border (Pringault
et al. 1991); and the gene coding for the interleukin 8
receptor alpha (IL8RA). Considering the clinical char-
acteristics of the disease, neither villin nor an interleu-
kine receptor represents a tempting candidate gene. Con-
firmation of the causative character of the disease
mutation may not be easy, since all the disease chro-
mosomes most probably carry the same mutation and
the same polymorphisms. The discovery of individuals
with this disease elsewhere in the world would make the
task easier.
Cloning of the disease-causing gene would be essential
to reveal the pathogenesis of this disease, which still is
a mystery. Assignment of the disease locus to a well-
defined chromosomal region already provides the pos-
sibility of prenatal diagnostics for families with at least
one affected child as well as carrier diagnostics for un-
affected sibs and other relatives.
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